10 05 2021
Without explanation (that we can see), the Bangkok Post has changed an online story. Guess what it is about? The king’s Siam Bioscience company. It might be a small thing, but it is illustrative of how the system works. Someone got upset, got on the phone and the story gets changed. If it was legitimate, you’d expect a note, but not in royalist Thailand.
Here’s the original story:
Siam Bioscience-produced AstraZeneca vaccine passes quality testing
9 May 2021 at 13:31
Samples from test batches of the Covid-19 vaccine made by Siam Bioscience have passed quality testing at AstraZeneca’s designated laboratories in Europe and the United States, the company announced on Sunday.
Thai-produced AstraZeneca vaccine passes quality testing
Thai-produced AstraZeneca vaccine passes quality testing
BANGKOK: Samples from test batches of the Covid-19 vaccine made by Siam Bioscience have passed quality testing at AstraZeneca’s designated laboratories in Europe and the United States, the company announced on Sunday (May 9), Bangkok Post reports.
Sunday 9 May 2021, 04:30PM
A health worker holds a syringe and a vial of the imported AstraZeneca vaccine on March 31, 2021. Photo: Wichan Charoenkiatpakul / Bangkok Post
In a press release – in English but with numerous grammatical errors – James Teague, Country President, AstraZeneca (Thailand) Ltd said: We have seen a series of significant and promising progress [sic] in AstraZeneca’s Covid-19 vaccine development in Thailand during the past weeks. First, the Thai Food and Drug Administration approved Siam Bioscience as a manufacturing facility for COVID-19 vaccine AstraZeneca. Last week, the samples of COVID-1
BANGKOK (The Nation/ANN): AstraZeneca announced on Sunday (May 9) that the samples from test batches of the Covid-19 vaccine made by Siam Bioscience had passed the quality testing at AstraZeneca’s designated laboratories in Europe and in the US.
James Teague, Country President, AstraZeneca (Thailand) Ltd., said: “We have seen a series of significant and promising progress in AstraZeneca’s Covid-19 vaccine development in Thailand during the past weeks First, the Thai Food and Drug Administration approved Siam Bioscience as a manufacturing facility for Covid-19 Vaccine AstraZeneca Last week, the samples of Covid-19 Vaccine AstraZeneca made by Siam Bioscience passed the full tests the standard set by the Department of Medical Sciences (DMS) for requirements such as chemical composition and safety.. And today, I am happy to be able to inform you that the samples from test batches of the Covid-19 vaccine made by Siam Bioscience had passed the quality testing at AstraZeneca’s
Thailand accelerates production of AstraZeneca COVID-19 vaccine
Thailand accelerates production of AstraZeneca COVID-19 vaccine 30 April 2021 | News The Food and Drug Administration of Thailand has approved Siam Bioscience as a manufacturing facility for COVID-19 Vaccine AstraZeneca
Photo Credit: Freepik
Thailand s Food and Drug Administration (FDA) has approved Siam Bioscience as a manufacturing facility for COVID-19 Vaccine AstraZeneca. The first batch of the vaccine will be ready for delivery to the Thailand Government in June of this year.
AstraZeneca, together with Siam Bioscience, is accelerating the production to support the national vaccination campaign. The collaboration with the Thailand Government and the FDA has facilitated the swift but careful progress with the manufacturing plant over the past few months.